Physiological Reports (Jan 2022)

Anti‐Müllerian hormone and vascular dysfunction in women with chronic kidney disease

  • Sandra M. Dumanski,
  • Todd J. Anderson,
  • Kara A. Nerenberg,
  • Jayna Holroyd‐Leduc,
  • Jennifer MacRae,
  • Satish R. Raj,
  • Amy Metcalfe,
  • Sharanya Ramesh,
  • Cindy Z. Kalenga,
  • Darlene Sola,
  • Milada Pajevic,
  • Sofia B. Ahmed

DOI
https://doi.org/10.14814/phy2.15154
Journal volume & issue
Vol. 10, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Young women with chronic kidney disease (CKD) have disproportionately increased risk of cardiovascular mortality. Reduced anti‐Müllerian hormone (AMH) is linked to poor cardiovascular outcomes in the general population, but whether AMH is associated with increased cardiovascular risk in the high‐risk CKD population is unknown. This study examined the association between AMH and vascular function, validated markers of cardiovascular risk, in women with CKD. An exploratory cross‐sectional study was performed in 47 young women with CKD. Laboratory measurements of AMH were collected. Using standardized protocols, endothelial function was measured with brachial artery flow‐mediated dilation and hyperemic velocity time integral. Arterial stiffness was measured with aortic augmentation index and pulse wave velocity. Multivariate linear regression analyses were utilized to evaluate the association between AMH levels and each measure of vascular health. Forty women (36 ± 7 years) with non‐dialysis‐dependent CKD and 7 women (38 ± 6 years) with dialysis‐dependent CKD participated. AMH levels were inversely associated with age (p = 0.01) but not associated with eGFR (p = 0.59) or dialysis status (p = 0.97). AMH was associated with brachial artery flow‐mediated dilation (R2 = 0.21 [p = 0.03]) and aortic augmentation index (R2 = 0.20 [p = 0.04]) in the non‐dialysis‐dependent participants, and with aortic augmentation index in all participants (R2 = 0.18 [p = 0.03]). No association between AMH and any measure of vascular function was demonstrated in the dialysis‐dependent participants. AMH levels are associated with impaired vascular function in young women with CKD and may be an important marker of future cardiovascular risk. Further investigation into this female‐specific cardiovascular risk factor is warranted in this high‐risk population.

Keywords